Biotech, HIV, Aethlon
Aethlon Medical Starts First Trial of Device Against HIV
Luke Timmerman 9/29/08
San Diego-based Aethlon Medical (OTCBB: AETH) said today it has begun the first clinical trial of a medical device to treat HIV. The device, called Aethlon Hemopurifier, filters viruses and immune-suppressing proteins, in order to help the immune system fight HIV. The trial, of six patients, is being conducted in India.
Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.





